Jabil’s (NYSE:JBL) Jabil Healthcare division announced today that it launched its Qfinity auto-injector platform. St. Petersburg, Florida-based Jabil Healthcare designed the reusable Qfinity platform for simple subcutaneous drug self-administration at a lower cost than market alternatives. Get the full story at our sister site, Drug Delivery Business News.